Zoom's November pain started in the first week of the month. Pharmaceuticals giant Pfizer presented strong results from trials of an anti-coronavirus pill, driving many stocks sharply higher as ...

Zoom Communications (ZM) has quietly slipped about 5% over the past month, even as its AI first workplace story keeps evolving and long term returns remain surprisingly mixed for such a well known ...